CRF2 Agonist for the Treatment of Worsening Heart Failure

NCT06815471 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
300
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Corteria Pharmaceuticals

Collaborators